Literature DB >> 6813480

Effects of auranofin on the radiological progression of joint erosion in rheumatoid arthritis.

J P Gofton, W M O'Brien.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813480

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


× No keyword cloud information.
  9 in total

1.  Radiological evaluation of erosions: a quantitative method for assessing long-term remittive therapy in rheumatoid arthritis.

Authors:  W M O'Brien
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

2.  Effect of sulphasalazine on the radiological progression of rheumatoid arthritis.

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

Review 3.  Assessing the progression of joint damage in rheumatoid arthritis.

Authors:  D L Scott; M Farr
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Prediction of radiographic damage in hands and feet in rheumatoid arthritis by clinical evaluation.

Authors:  M J Plant; J Saklatvala; P W Jones; P T Dawes
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

Review 5.  Current status of disease-modifying drugs in progressive rheumatoid arthritis.

Authors:  J D O'Duffy; H S Luthra
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

Review 6.  Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.

Authors:  M Chaffman; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

Review 7.  New perspectives of secondary and tertiary therapy for rheumatoid arthritis.

Authors:  R F Willkens
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

8.  Radiological progression in rheumatoid arthritis: how many patients are required in a treatment trial to test disease modification?

Authors:  J T Sharp; F Wolfe; M Corbett; H Isomaki; D M Mitchell; D E Furst; J Sibley; M Shipley
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

9.  Antiarthritic synergism of combined oral and parenteral chrysotherapy. I. Studies in adjuvant-induced arthritis in rats.

Authors:  A E Finkelstein; M Ladizesky; R Borinsky; E Kohn; I Ginsburg
Journal:  Inflammation       Date:  1988-08       Impact factor: 4.092

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.